»
Antibodies
»
anti-Human Class II beta-Tubulin antibody
Human Class II beta-Tubulin antibody
| Antigen |
|
| Synonyms |
MC1R, TUBB4, beta-4, TUBB3, MGC134115, tbb3 |
| Clonality |
Monoclonal (Cov7B9) |
|
Host
|
|
|
Reactivity
|
|
|
Application
|
Alternatives Immunocytochemistry (ICC), Immunoprecipitation (IP), Western Blotting (WB)
|
| Catalog no. |
ABIN346894 |
| Quantity |
100 µl (Variants) |
| Price |
377.00 $ Plus shipping costs $35.00
|
| Shipping to |
|
| Availability |
Ships within 3 to 5 Business Days |
|
Immunogen
|
CII beta-Tubulin protein
|
|
Format
|
Ascites
|
|
Isotype
|
IgG1 kappa (Matching secondary antibodies)
|
|
Clone
|
Cov7B9
|
|
Specificity
|
Monoclonal antibody reacts specifically with human class II beta-Tubulin (10 kDa). Cross Reactivities: Not yet tested
|
|
Application Notes
|
Optimal dilutions should be determined by the end user. The following are guidelines only: Immunocytochemistry : 1/200 to 1/1 000. Immunoprecipitation : 1/50 to 1/200. Western Blot : 1/200 to 1/1 000
|
|
Buffer
|
Lyophilized from 100 µl of ascitic fluid. Preservative: None.
|
|
Storage
|
Short term storage: +4°C. Long term storage: -20°C
|
|
Restrictions
|
For Research Use only
|
|
Publications
|
Sueve, Reiman, Lai et al.: "Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site." in: Cancer chemotherapy and pharmacology, Vol. 60, Issue 1, pp. 27-34, 2007 (PubMed).
Sueve, Lai, Ding et al.: "Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, Issue 3, pp. 994-9, 2007 (PubMed).
|
Alternatives for antigen "Human Class II beta-Tubulin", type "Antibodies"